Want to join the conversation?
$ADS 2Q15 PR: Revenue was $1,500.6MM vs. $1,265.2MM in 2Q14. Operating income was $285.7MM vs. $282.5MM in 2Q14. Net income attributable to shareholders $131.3MM vs. $137.4MM in 2Q14. Diluted EPS was $2.11 vs. $2.19 in 2Q14. Operating expenses were $1,214.9MM vs. $982.7MM in 2Q14.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)